Close Menu

NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market Thursday that its first quarter revenues decreased 1 percent year over year due primarily to sagging instrument revenue.

For the three months ended March 31, the South San Francisco, California-based life science research tools firm logged $25.2 million in revenues compared to $25.5 million in the year-ago quarter. This included $20.5 million in product revenue and $4.8 million in service revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.